The fourth-quarter 2024 earnings cycle is here, with quite a few healthcare companies having reported results. Early reports ...

Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

Empresas CMPC reported its fourth-quarter 2024 earnings, revealing a slight miss on earnings per share (EPS) and revenue forecasts. The company posted an EPS of $0.01, falling short of the projected ...

Core earnings for 2024 were $3.1 billion, or $10.30 per diluted share, up 11% from $2.8 billion, or $8.88 per diluted share, ...

Tempus AI (NASDAQ:TEM) wasn’t that remarkable compared to most other AI high-fliers in the past year. The stock was very volatile in the past year and declined significantly in December 2024. TEM ...

ArcBest beat fourth-quarter expectations Friday but noted that continued industrial weakness is weighing on its results.

In comparison with the previous month, consumer prices in January 2025, according to the forecast, will decrease by 0.2 percentage points ...

Canadian National Railway Company stock offers a strong long-term investment opportunity with a 29-year dividend growth ...

Twilio (NYSE: TWLO) stock has been red-hot on the market in the past six months, rising an incredible 148% as of this writing as investors seem to have recognized the potential impact of the growing ...

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.

We recently published a list of Jim Cramer Discusses These 10 Stocks, The Fed Chair & Lower AI Costs. In this article, we are ...

MSCI’s Q4 results and slow growth prospects suggest limited upside. Find out why MSCI stock, with modest revenue growth, is ...